Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease
- 1 January 2010
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 104 (11), 1009-1021
- https://doi.org/10.1160/th10-06-0360
Abstract
This study reports on the evaluation of seven commercial von Wille-brand factor (VWF) collagen binding (VWF:CB) assays to potentially assist the discrimination of types 1 and 2 von Willebrand disease (VWD). Samples from 25 patients with type 1 VWD, of varying severity, were co-tested with 16 samples from patients with types 2A or 2B VWD, plus various control samples, using each commercial VWF:CB assay assessed against our standard (reference) in-house VWF:CB assay, as well as our in-house VWF antigen (VWF:Ag) and ristocetin cofactor (VWF:RCo) assays. Commercial VWF:CB assays varied in their ability to discriminate types 1 and 2A/2B VWD. The optimal VWF:CB/VWF:Ag ratio at which optimal discrimination occurred also differed between assays, with some improvements observed with some (but not all) as-says following a harmonisation process that aimed to correct for different calibrator effects. Assay variability also compromised assay utility in some test occasions. Future standardisation and improvements in some commercial VWF:CB assays are needed before the VWF:CB assay can be more fully and globally utilised for discrimination of VWD types in diagnostic laboratories.This publication has 21 references indexed in Scilit:
- Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heartThrombosis and Haemostasis, 2010
- A better approach to monitoring of therapy in von Willebrand disease?Thrombosis and Haemostasis, 2008
- PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Thrombosis and Haemostasis, 2008
- von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2Journal of Thrombosis and Haemostasis, 2007
- Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboonsThrombosis and Haemostasis, 2007
- The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding timeThrombosis and Haemostasis, 2007
- External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing ProgramSeminars in Thrombosis and Hemostasis, 2006
- An External Quality Assessment Program for von Willebrand Factor Laboratory Analysis: An Overview from the European Concerted Action on Thrombosis and Disabilities FoundationSeminars in Thrombosis and Hemostasis, 2006
- von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2MJournal of Thrombosis and Haemostasis, 2006
- An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand diseaseThrombosis and Haemostasis, 2006